Can Hexo (TSX:HEXO) Stock Double Your Wealth in 2020?

Is it time to consider Hexo stock after an 80% decline since April 2019?

| More on:

Shares of Canada-based marijuana company Hexo (TSX:HEXO)(NYSE:HEXO) are currently trading at $1.98. The stock has lost over 80% since April 2019 and has been one of the worst-performing stocks in the cannabis sector since the start of 2019.

But we know that the optimism surrounding Cannabis 2.0 coupled with the rollout of retail stores in Ontario will hold pot companies in good stead. Further, the decimation witnessed last year has resulted in lower valuations. Hexo is trading at a market cap of $540 million, or 6.6 times forward sales, which might be considered attractive.

What are Hexo’s competitive advantages?

Hexo is one of the top pot companies in Canada. It wants to become a market leader in the adult-use cannabis space with brands such as Hexo, UP, Original Stash, and “powered by Hexo.” The company claims to have the lowest-cost production centres in Canada with a broad distribution network across 10 provinces. Hexo has invested heavily in research to enhance product offerings and customer experiences and has partnerships with global CPG companies.

Hexo is the first to launch a cannabis oil sublingual spray. It is the first licensed producer (LP) in Canada to join the Food & Consumer Products of Canada, which is the country’s largest association representing this industry. Hexo is also the first LP to obtain Kosher certification and partner with a firm in the plant tissue culture space.

Strategic priorities

Hexo has focused on new product offerings as well as leveraging data analytics for decision making to drive top-line growth. As most cannabis companies, including Hexo, are struggling with low profit margins, it is now looking to streamline the supply chain and automate business processes to improve the bottom line.

To achieve its spending targets, Hexo has realigned operating expenses with near-term revenue expectations. Another strategy has been the company’s focus on opening facilities in provinces that have a cost advantage.

Hexo launched a low-cost product known as Original Stash and is priced to compete with Canada’s illegal market, which still accounts for close to 40% of the total market.

Huge market opportunity

Hexo is expected to launch in the United States in 2020. According to Hexo’s presentation, the North American market for cannabis-infused beverages will reach $1.56 billion this year. The global cannabis-infused beverage market is valued at $5.04 billion.

The company has access to 98% of Canada’s population due to its vast distribution network. It has a 33% market share in Quebec, which is the second-largest province in the country. Hexo’s partnership with Molson Coors will help it gain significant traction in the cannabis-infused beverage market.

Molson Coors is a market leader in beverage distribution in Canada, U.S., Mexico, and the United Kingdom. This is a standalone joint venture where costs and profits will be shared on a pro-rata basis.

We can see that Hexo, like so many other players, is banking on future growth and investing heavily in capital expenditures. But the slow rollout of retail stores, competition from the illegal market, and lower-than-expected vaping sales will continue to impact pot stocks in the next few quarters.

The upcoming earnings season will be critical in case marijuana companies are able to reduce inventory levels and drive profit margins higher. Analysts remain cautious for a reason. But is it time to consider pot stocks once again, since the massive decline in valuations over the last year?

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »